Biotechnology was a glistening theme in yesterday’s session. An FDA approval on a drug and positive test results for another drug spurred big gains in 2 of the biotech stocks, which put the focus on healthcare generally, once again.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
